VectorY Therapeutics
VectorY Therapeutics is an Amsterdam-based fully integrated gene therapy company developing vectorized antibody treatments for neurodegenerative diseases including ALS. Founded in August 2020, VectorY combines AAV-based gene therapy with antibody science and operates proprietary R&D and GMP manufacturing facilities at Amsterdam Science Park.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2023
Jun 2021
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
